Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Jenscare Scientific Co. Ltd. Class H ( (HK:9877) ) is now available.
Jenscare Scientific Co., Ltd. has scheduled a board meeting for March 26, 2026 to review and approve the group’s annual results for the year ended December 31, 2025 and to authorize their publication. The board will also consider recommending a final dividend, if any, and address other corporate matters, signaling routine but important governance steps that may influence shareholder returns.
The meeting underscores the company’s adherence to disclosure and governance practices expected of Hong Kong–listed issuers and will set the basis for communicating 2025 financial performance to the market. Any decision on a final dividend could affect investor sentiment and indicate management’s confidence in the company’s financial health and cash-generation capacity.
More about Jenscare Scientific Co. Ltd. Class H
Jenscare Scientific Co., Ltd. is a medical technology company based in the People’s Republic of China and listed in Hong Kong under stock code 9877. The group focuses on developing and commercializing innovative scientific and medical solutions, positioning itself within the broader healthcare and life sciences industry.
Average Trading Volume: 203,625
Technical Sentiment Signal: Hold
Current Market Cap: HK$4.91B
Find detailed analytics on 9877 stock on TipRanks’ Stock Analysis page.